国家药监局副局长黄果在四川调研放射性药品研发工作

Core Viewpoint - The National Medical Products Administration (NMPA) is actively engaging with the radioactive pharmaceutical industry to enhance research, quality management, and regulatory science [1] Group 1 - The NMPA's deputy director, Huang Guo, led a team to visit radioactive pharmaceutical R&D and production companies in Sichuan [1] - The visit included discussions on the development of radioactive pharmaceuticals and the importance of comprehensive quality management [1] - The focus of the research also included regulatory science, indicating a commitment to improving oversight in this sector [1]